SCHEMBL15958641

SCHEMBL15958641

COc1nc2ccccc2nc1-c1nnn(C)c1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.45
L3MBTL1 Q9Y468 4/20 0.45
ALDH1A1 P00352 4/20 0.45
LMNA P02545 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
NPC1 O15118 1/20 0.44
NFKB1 P19838 1/20 0.44
RAB9A P51151 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GAA P10253 2/20 0.42
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HRH4 Q9H3N8 2/20 0.40
KEAP1 Q14145 2/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
CASP1 P29466 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14218180 0.85 HRH4 (0.45) KDM4EL3MBTL1ALDH1A1LMNATDP1
SCHEMBL12669846 0.85 AKT1 (0.38) KDM4EL3MBTL1ALDH1A1LMNATDP1
SCHEMBL7735370 0.78 KDM4E (0.65) KDM4EL3MBTL1ALDH1A1LMNATDP1
SCHEMBL15958639 0.77 KDM4E (0.51) KDM4EL3MBTL1ALDH1A1LMNATDP1
SCHEMBL27555336 0.76 NPC1 (0.36) KDM4EL3MBTL1ALDH1A1LMNATDP1
SCHEMBL822713 0.76 KEAP1 (0.45) KDM4EALDH1A1LMNATDP1NPC1
SCHEMBL7681595 0.75 NR1I3 (0.37) KDM4EL3MBTL1ALDH1A1LMNATDP1
SCHEMBL27413977 0.71 SMN1; SMN2 (0.39) KDM4EL3MBTL1ALDH1A1LMNATDP1
SCHEMBL15958653 0.69 KDM4E (0.49) KDM4EL3MBTL1ALDH1A1LMNATDP1
SCHEMBL7474377 0.68 NQO2 (0.56) KDM4EL3MBTL1ALDH1A1LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809264-B2 Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2014-08-19 US disclosed